...
首页> 外文期刊>Journal of clinical virology: The official publication of the Pan American Society for Clinical Virology >Early neutralizing and glycoprotein B (gB)-specific antibody responses to human cytomegalovirus (HCMV) in immunocompetent individuals with distinct clinical presentations of primary HCMV infection.
【24h】

Early neutralizing and glycoprotein B (gB)-specific antibody responses to human cytomegalovirus (HCMV) in immunocompetent individuals with distinct clinical presentations of primary HCMV infection.

机译:在具有原发性HCMV感染的不同临床表现的免疫活性个体中,早期中和和糖蛋白B(gB)特异性抗体对人巨细胞病毒(HCMV)的反应。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Antibodies with functional anti-Human Cytomegalovirus (HCMV) activity are likely to be involved in preventing virus dissemination and thus may contribute to minimize the clinical manifestations of infection. OBJECTIVES: To investigate the role of humoral immunity in modulating the clinical expression of primary Human Cytomegalovirus (HCMV) infection in immunocompetent persons. STUDY DESIGN: Neutralizing (NA) and glycoprotein B (gB)-specific antibodies were quantitated in acute-phase and late-convalescence phase sera from 19 individuals who developed either HCMV mononucleosis (12) or oligosymptomatic hepatitis (seven). RESULTS: The levels of NA in sera drawn early after infection were significantly lower in the former patients than in the latter (P=0. 032). This difference was not related to either the total serum IgG levels and anti-HCMV IgGs avidity or to the presence of higher viral loads in blood, as assessed by detecting serum HCMV DNA by PCR, in patients experiencing mononucleosis. Increased NA titers were seen in all available late-convalescence sera. In these sera, median NA levels were not significantly different among the study groups. Antibodies to HCMV gB of both IgG and IgM classes were detected in all acute-phase sera analyzed. Median anti-gB IgG and IgM titers did not differ significantly between study groups. Likewise, the IgG subclass reactivity pattern against gB was found to be similar for both groups. CONCLUSIONS: The data revealed that an intense and early antibody response to gB developed in patients undergoing primary HCMV infection irrespective of the clinical manifestation of the disease. In contrast, a deficient NA response was observed in patients with HCMV mononucleosis versus that observed in patients displaying a milder form of disease-suggesting that the strength of NA response to HCMV generated early after infection might determine the severity of primary HCMV infection.
机译:背景:具有功能性抗人巨细胞病毒(HCMV)活性的抗体可能与预防病毒传播有关,因此可能有助于最大程度地减少感染的临床表现。目的:探讨体液免疫在调节具有免疫能力的人中原发性人巨细胞病毒(HCMV)感染的临床表达中的作用。研究设计:从19例HCMV单核细胞增多症(12)或少症状性肝炎(7)个体的急性期和恢复期后期血清中定量中和(NA)和糖蛋白B(gB)特异性抗体。结果:感染后早期抽取的血清中NA水平显着低于后者(P = 0.032)。这种差异与单核细胞增多症患者的血清总IgG水平和抗HCMV IgG亲和力无关,也与血液中较高的病毒载量无关。在所有可用的后期恢复血清中均发现NA滴度增加。在这些血清中,研究组之间的中值NA水平无显着差异。在所有分析的急性期血清中均检测到IgG和IgM类的HCMV gB抗体。研究组之间的抗gB IgG和IgM效价中位数无显着差异。同样,发现两组的针对gB的IgG亚类反应模式相似。结论:数据显示,在原发性HCMV感染患者中,无论疾病的临床表现如何,均会对gB产生强烈的早期抗体反应。相反,在HCMV单核细胞增多症患者中观察到NA反应不足,而在显示较轻形式疾病的患者中观察到NA反应不足,这表明在感染后早期产生的对HCMV的NA反应强度可能决定了原发性HCMV感染的严重程度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号